NCT01612351 2026-03-17
Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
Phase 2 Completed
UNC Lineberger Comprehensive Cancer Center
Merck Sharp & Dohme LLC
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Shanghai Jiao Tong University School of Medicine
Shanghai Chest Hospital